Drugs / Biest
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00864214 | Jun 2008 → Dec 2009 | — | Mayo Clinic | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05645393 Comparator | Jun 2024 → Mar 2025 | — | University of Maryland, Baltimore | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biest | “Biest cream (equivalent dose to EstroGel®)” NCT05645393 ↗ |
| Known as | Bi-est (80:20) | “one of three doses of a compounded estrogen cream (Bi-est (80:20); 2.0, 2.5, or 3.0 mg)+compounded oral progesterone 100 mg” PMID 23384975 ↗ Feb 2013 |